Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 1;143(4):1099-1105.
doi: 10.1093/brain/awaa051.

A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants

Affiliations

A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants

Javier A López-Rivera et al. Brain. .

Abstract

A large fraction of rare and severe neurodevelopmental disorders are caused by sporadic de novo variants. Epidemiological disease estimates are not available for the vast majority of these de novo monogenic neurodevelopmental disorders because of phenotypic heterogeneity and the absence of large-scale genomic screens. Yet, knowledge of disease incidence is important for clinicians and researchers to guide health policy planning. Here, we adjusted a statistical method based on genetic data to predict, for the first time, the incidences of 101 known de novo variant-associated neurodevelopmental disorders as well as 3106 putative monogenic disorders. Two corroboration analyses supported the validity of the calculated estimates. First, greater predicted gene-disorder incidences positively correlated with larger numbers of pathogenic variants collected from patient variant databases (Kendall's τ = 0.093, P-value = 6.9 × 10-6). Second, for six of seven (86%) de novo variant associated monogenic disorders for which epidemiological estimates were available (SCN1A, SLC2A1, SALL1, TBX5, KCNQ2, and CDKL5), the predicted incidence estimates matched the reported estimates. We conclude that in the absence of epidemiological data, our catalogue of 3207 incidence estimates for disorders caused by de novo variants can guide patient advocacy groups, clinicians, researchers, and policymakers in strategic decision-making.

Keywords: autism; epilepsy; incidence; neurodevelopmental disorder.

PubMed Disclaimer

Figures

Figure 1 Gene-variant intolerance.
Figure 1 Gene-variant intolerance.
(A) Distribution of intolerance to protein-coding variation of established de novo NDD genes by intolerance type. MV = missense variant intolerant; MV & PTV = intolerant to both missense and truncating variants. (B) Total predicted sporadic disease incidence due to established de novo variant-associated disease genes. Error bars represent 90% CIs.

Comment in

Similar articles

Cited by

References

    1. Auvin S, Irwin J, Abi-Aad P, Battersby A.. The problem of rarity: estimation of prevalence in rare disease. Value Health 2018; 21: 501–7. - PubMed
    1. Barisic I, Boban L, Greenlees R, Garne E, Wellesley D, Calzolari E, et al.Holt Oram syndrome: a registry-based study in Europe. Orphanet J Rare Dis 2014; 9: 156. - PMC - PubMed
    1. Bayat A, Hjalgrim H, Moller RS.. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009. Epilepsia 2015; 56: e36–9. - PubMed
    1. Carvill GL, Engel KL, Ramamurthy A, Cochran JN, Roovers J, Stamberger H, et al.Aberrant inclusion of a poison exon causes Dravet syndrome and related SCN1A-associated genetic epilepsies. Am J Hum Genet 2018; 103: 1022–9. - PMC - PubMed
    1. Chen WH, Lu G, Chen X, Zhao XM, Bork P.. OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines. Nucleic Acids Res 2017; 45: D940–4. - PMC - PubMed

Publication types